Specialist expertise: Coronary Artery Disease, Structural Heart Disease including PFO, ASD and the TAVI procedure, Cardiology, Interventional Cardiology, Breathlessness, Chest Pain, Blood Pressure, Type 1 & 2 Diabetes, Stroke, Heart Health, Valve Disease, Angina, Para-Valvular Leak Closure.
We often use anti-platelet drugs to stop the blood clotting. They act to make platelets, the blood cells involved in forming a clot when you bleed, less sticky. In patients with proven heart attack or stroke, the the enemy is the clot. Aspirin in combination with other agents, such as Clopidogrel or Ticagrelor, is used after heart attack and coronary stents. After a stroke, aspirin is often seen as not strong enough, and Clopidogrel is used more often. However, if the stroke is related to atrial fibrillation, a common heart rhythm problem, then neither aspirin or Clopidogrel are strong enough, and agents such as Warfarin, Rivaroxaban, Edoxaban, Dabigatran, and Apixaban are used. The newer (non-Warfarin agents) have the advantage of not needing regular blood tests and having standard dose regimes, some of which are only once a day.